Malaria Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Technology (Molecular Diagnostic Tests, Rapid Diagnostic Test, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Home care, Others), By Region and By Competition

Global malaria diagnostics market is anticipated to grow at a rapid pace in the forecast period, 2024-2028. This is attributed to the growing government fundings, increase in research and development activities (R&D), and rise in the number of people suffering from malaria across the world. Malaria is a life-threatening disease caused by the Plasmodium parasite, which is transmitted to humans through the bite of infected female Anopheles mosquitoes. It is a major public health concern, particularly in tropical and subtropical regions, where the conditions are favorable for mosquito breeding and malaria transmission. The Malaria diagnostic market plays a critical role as it ensures the early and accurate diagnosis of malaria. Also, the malaria diagnostics helps to ensure that the patient is receiving the appropriate treatment, preventing the overuse of drugs, providing important disease surveillance data, and reducing the spread of malaria.

According to the World Health Organization (WHO), there were approximately 247 million cases of malaria reported worldwide in 2021, out of which 6,19,000 number of malaria deaths were estimated. The WHO African Region carries a disproportionately large amount of the worldwide malaria burden. In 2021, the Region witnessed 95% of malaria cases and 96% of malaria deaths.

High Prevalence of Malaria

Increasing prevalence of malaria across the world is influenced by various factors, including the presence of the mosquito vector that transmits the parasite, environmental factors that support mosquito breeding, access to effective malaria prevention and control measures, and the level of immunity to the disease in the population. Therefore, to reduce the prevalence of malaria, it is essential to implement effective malaria control strategies, such as early diagnosis and prompt treatment of malaria cases. The rowing prevalence of malaria can influence the demand and uptake of malaria diagnostic tests, which in turn, is expected to bolster the growth of the global malaria diagnostic market in the upcoming years. Rapid diagnostic tests (RDTs) and microscopy are commonly used to diagnose malaria, and accurate diagnosis is essential for effective disease management and control.

According to the World Health Organization’s 2021 report, approximately 50% of global malaria fatalities were attributed to just four African nationsNigeria (31.3%), the Democratic Republic of the Congo (12.6%), United Republic of Tanzania (4.1%), and Niger (3.9%).

Increasing Investments and Technological Advancements

Global malaria diagnostic market has seen significant growth in recent years, and this can largely be attributed to the high prevalence of malaria in many countries. As the demand for malaria diagnostic tests increases, companies that produce these tests are expanding their operations and investing in research and development to improve the accuracy, sensitivity, and cost-effectiveness of their products. The high burden of malaria in many countries has driven the growth of the malaria diagnostic market. This high prevalence of malaria has led to a significant demand for malaria diagnostic tests, including rapid diagnostic tests (RDTs) and microscopy. In response to this demand, many companies have invested in the production and distribution of malaria diagnostic tests. These tests have become increasingly accessible in many countries, including those with a high burden of malaria. Companies producing malaria diagnostic tests have also focused on improving the accuracy, sensitivity, and cost-effectiveness of their products, making them more attractive to healthcare providers in resource-limited settings. Also, the growth of the global malaria diagnostic market has also been driven by technological advancements in diagnostic technologies. For example, there has been a significant shift towards the use of molecular diagnostic tests, such as polymerase chain reaction (PCR) tests, which can provide more accurate and sensitive results than traditional microscopy and RDTs. These new technologies are improving the accuracy of malaria diagnosis and helping to reduce the burden of the disease in many countries. In addition, another promising development in the field of malaria diagnostics is the use of artificial intelligence (AI) and machine learning (ML) algorithms to improve the accuracy and speed of malaria diagnosis. These tools can analyze large datasets of malaria cases to identify patterns and predict disease outbreaks, helping to inform public health interventions. Also, increase in research and development activities are done in order to develop new malaria diagnostic tools, such as biosensors and nanotechnology-based tests, which have the potential to improve the speed, sensitivity, and specificity of malaria diagnosis. These advancements as well as the introduction of novel malaria diagnostic techniques are expected to drive the growth of the global malaria diagnostic market in the forthcoming years.

Increasing Government Funding

For example, the Global Fund to Fight AIDS, Tuberculosis and Malaria, which is a partnership between governments, civil society, and the private sector, has played a significant role in funding malaria control programs in many countries.

Recent Developments

In 2022, a combined RT-PCR test called PathoDetect Extended Monsoon Fever Panel was launched by Mylab Discovery Solutions. This test is designed to identify monsoon-related illnesses such as malaria, dengue, Chikungunya, Leishmaniasis parasites, Zika, Leptospirosis and Salmonellosis bacterial species.

In 2022, SC Johnson and Global Fund joined forces with the aim of eliminating malaria. The Global Fund is responsible for 56% of all international funding for malaria programs, which accounts for 39% of the total found at resources. So far, the organization has contributed over USD 16 billion towards malaria control programs.

In 2022, a Plasmochek diagnostic kit was launched by the Kenya Medical Research Institute (KEMRI) for malaria.

In 2023, the India Health Fund (IHF), which is a funding initiative by Tata Trusts, has announced its support for the two platform tools developed by Ameliorate Biotech Pvt Ltd and Medprime Technologies, the tools are a fever panel to detect chikungunya, dengue, malaria and microscope-agnostic AI-enabled diagnosis software that is applicable across diseases.

Download Free Sample Report

Market Segmentation

Global malaria diagnostics market is segmented into technology, end user, company, and region. Based on technology, the global malaria diagnostics market is segmented into molecular diagnostics tests, rapid diagnostic tests, and others. Based on end user, the global Malaria diagnostics market is divided into hospitals & clinics, diagnostic centers, home care, and others. In terms of region, the Middle East & Africa dominated the global malaria diagnostics market on account of the increasing research & development activities along with an increase in the number of people suffering from malaria.

Market Players

Access Bio., Inc., Abbott Laboratories, Inc., bioMérieux SA, altona Diagnostics GmbH, Bio-Rad Laboratories, Inc., AdvaCare Pharma, Meril Life Sciences Pvt. Ltd.,